The contribution of second primary cancers to the mortality of patients with a first primary breast cancer

• Autor(es): Gonçalves, E ; Fontes, F ; Rodrigues, JR ; Calisto, R ; Bento, MJ ; Lunet, N ; Morais, S
• Data: 2024
• Identificador Persistente: https://hdl.handle.net/10216/160580
• Origem: Repositório Aberto da Universidade do Porto
• Tipo de Documento: Artigo científico
• Idioma: Inglês

Descrição

Purpose: Second primary cancers (SPCs) are estimated to affect nearly 5% of patients with breast cancer within 10 years of their diagnosis. This study aimed to estimate the contribution of SPCs to the mortality of patients with a breast first primary cancer (FPC). Methods: A population-based cohort of 17,210 patients with a breast FPC diagnosed between 2000 and 2010 was followed for SPCs (31/12/2015) and vital status (30/06/2021). Patients diagnosed with an SPC (265 synchronous and 897 metachronous, ≤ 1 and > 1 year after the FPC, respectively) were matched (1:3, by five-year age group and year of breast FPC diagnosis) to those without an SPC and alive when the corresponding SPC was diagnosed. Results: Significantly higher hazards of death were found among patients with an SPC [hazard ratio of 1.56, 95% confidence interval (CI) 1.29–1.89 for synchronous SPCs; and 2.85, 95%CI 2.56–3.17 for metachronous SPCs] compared to patients with a breast FPC only. Estimates were higher for synchronous lung, stomach, non-Hodgkin lymphoma and breast SPCs, and metachronous liver, stomach, ovary, lung, rectum, corpus uteri, colon, breast, and non-Hodgkin lymphoma SPCs. The 15-year cumulative mortality was 59.5% for synchronous SPCs and 68.7% for metachronous SPCs, which was higher than in patients with a breast FPC only (43.6% and 44.8%, respectively). Conclusions: In Northern Portugal, patients with an SPC following a breast FPC have a higher mortality compared with patients with a breast FPC only. © The Author(s) 2024.